• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HEMOSPHERE, INC. HERO GRAFT; VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HEMOSPHERE, INC. HERO GRAFT; VASCULAR GRAFT Back to Search Results
Model Number HERO 1002
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pulmonary Embolism (1498)
Event Date 10/10/2014
Event Type  Death  
Event Description
According to the report, the patient had a pulmonary embolism.As it is unknown whether hero 1001 or hero 1002 contributed to the event, out of caution, both product codes are being investigated.This medwatch is for product code hero 1002.
 
Manufacturer Narrative
According to the report, the patient had a pulmonary embolism.As it is unknown whether hero 1001 or hero 1002 contributed to the event, out of caution, both product codes are being investigated.This medwatch is for product code hero 1002.Attempts were made to request additional information on (b)(6) 2014, (b)(6) 2014, (b)(6) 2014, (b)(6) 2015, (b)(6) /2015, (b)(6) 2015, and (b)(6) 2015.The only additional information that was received was that the hero surgery took place on (b)(6) 2014, the pulmonary embolism occurred on (b)(6) 2014, the patient received intravenous (iv) systemic tissue plasminogen activator (tpa) lysis, recovered, and was discharged home on (b)(6) 2014.The information indicated that the patient "died one month ago," which would have placed the date of death approximately (b)(6) 2014.No further information was received as to the exact date of death or whether the death was related to the hero device.The manufacturing records for the possible lot numbers were reviewed and it was confirmed that all records were controlled, available for review, and met all specifications per the device master record.A review was performed of the available information.The hero graft instructions for use (ifu) indicate the graft may need maintenance due to thrombus and refers to the thrombectomy guidelines for additional information.The thrombectomy guidelines suggests removing clot from the venous portion before removing the arterial plug to reduce the patient's risk for developing pulmonary embolism (pe).The ifu also lists pe and/or death as potential adverse events.Table 2 of the ifu shows rates of 1.9% - 2.6% for pe and 0% - 1.9% for death.Additionally, the post-market retrospective multi-center study of 164 patients, gage, et al.Reported 29 deaths (17%) during a mean follow-up period of 15.4 months.The authors attributed the observed death rate to "the extreme morbidity of the end stage vascular access patients with central venous pathology." there is insufficient information to determine the source of the pulmonary embolus.Deep venous thrombosis of the pelvis and legs are common sources for pulmonary emboli.Thrombus within the hero graft is another possible source.Pulmonary embolus is a known potential complication of the hero device.Adequate precautions and warnings are provided in the instructions for use.Patient co-morbidities, such as a hypercoagulable state, that may predispose the patient to thrombotic events are unknown.There is insufficient information to determine the root cause for the pulmonary embolus and reported death.The role of the hero device in the reported events cannot be determined.
 
Event Description
According to the report, the patient had a pulmonary embolism.As it is unknown whether hero 1001 or hero 1002 contributed to the event, out of caution, both product codes are being investigated.This medwatch is for product code hero 1002.
 
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HERO GRAFT
Type of Device
VASCULAR GRAFT
Manufacturer (Section D)
HEMOSPHERE, INC.
1655 roberts blvd. nw
kennesaw GA 30144
Manufacturer (Section G)
HEMOSPHERE, INC.
1655 roberts blvd. nw
kennesaw GA 30144
Manufacturer Contact
sandra o'reilly
1655 roberts blvd., nw
kennesaw, GA 30144
7704193355
MDR Report Key4296767
MDR Text Key16304318
Report Number3006945290-2014-00102
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K121532
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/14/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberHERO 1002
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/14/2014
Initial Date FDA Received12/04/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received02/17/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Other;
-
-